Frequency of Modification of Pharmacological Treatment Is Equivalent for Virtual and In-Person Psychiatric Visits.
medication modification
outcomes
psychiatry
quality
telepsychiatry
virtual visits
Journal
Telemedicine reports
ISSN: 2692-4366
Titre abrégé: Telemed Rep
Pays: United States
ID NLM: 101773797
Informations de publication
Date de publication:
2023
2023
Historique:
accepted:
21
02
2023
entrez:
27
3
2023
pubmed:
28
3
2023
medline:
28
3
2023
Statut:
epublish
Résumé
During the coronavirus pandemic there was a rapid adoption of telehealth services in psychiatry, which now accounts for 40% of all visits. There is a dearth of information about the relative efficacy of virtual and in-person psychiatric evaluations. We examined the rate of medication changes during virtual and in-person visits as a proxy for the equivalence of clinical decision-making. A total of 280 visits among 173 patients were evaluated. The majority of these visits were telehealth (224, 80%). There were 96 medication changes among the telehealth visits (42.8%) and 21 among the in-person visits (37.5%) ( Clinicians were equally as likely to order a medication change if they saw their patient virtually or in person. This suggests that remote assessments yielded similar conclusions to in-person assessments.
Sections du résumé
Background
UNASSIGNED
During the coronavirus pandemic there was a rapid adoption of telehealth services in psychiatry, which now accounts for 40% of all visits. There is a dearth of information about the relative efficacy of virtual and in-person psychiatric evaluations.
Methods
UNASSIGNED
We examined the rate of medication changes during virtual and in-person visits as a proxy for the equivalence of clinical decision-making.
Results
UNASSIGNED
A total of 280 visits among 173 patients were evaluated. The majority of these visits were telehealth (224, 80%). There were 96 medication changes among the telehealth visits (42.8%) and 21 among the in-person visits (37.5%) (
Conclusion
UNASSIGNED
Clinicians were equally as likely to order a medication change if they saw their patient virtually or in person. This suggests that remote assessments yielded similar conclusions to in-person assessments.
Identifiants
pubmed: 36970220
doi: 10.1089/tmr.2023.0004
pii: 10.1089/tmr.2023.0004
pmc: PMC10036074
doi:
Types de publication
Journal Article
Langues
eng
Pagination
44-47Informations de copyright
© Amal Mumtaz et al., 2023; Published by Mary Ann Liebert, Inc.
Déclaration de conflit d'intérêts
R.S.E. has research funding from Sunovion, Roche, Janssen, and the Jesse H. Wright, MD, PhD. Endowment for Mood Disorders Research. He is a speaker for Axsome, Idorsia, Intracellular, Janssen, Lundbeck, Noven, Otsuka, and Sunovion. None of the other authors have any potential conflicts to declare.
Références
JAMA Netw Open. 2022 Jun 1;5(6):e2216401
pubmed: 35671053
Acad Psychiatry. 2016 Apr;40(2):317-20
pubmed: 26122354
World J Psychiatry. 2016 Jun 22;6(2):269-82
pubmed: 27354970
Science. 2021 Dec 03;374(6572):1202-1204
pubmed: 34793199
Am J Psychiatry. 2000 Nov;157(11):1762-8
pubmed: 11058471
J Am Med Inform Assoc. 2020 Jul 1;27(7):1132-1135
pubmed: 32324855
Soc Sci Med. 2001 Jun;52(12):1889-901
pubmed: 11352414
Health Policy Technol. 2020 Dec;9(4):623-638
pubmed: 32874854
Acta Biomed. 2020 Mar 19;91(1):157-160
pubmed: 32191675
Telemed J E Health. 2006 Oct;12(5):546-51
pubmed: 17042708
J Telemed Telecare. 2006;12(5):251-4
pubmed: 16848938
J Affect Disord. 2018 Oct 1;238:666-673
pubmed: 29966931
J Healthc Qual. 1994 Jan-Feb;16(1):14-7; quiz 17, 37
pubmed: 10135767
Psychopharmacol Bull. 2021 Jan 12;51(1):59-68
pubmed: 33897063